for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Siemens Healthineers AG

SHLG.DE

Latest Trade

60.16EUR

Change

1.40(+2.38%)

Volume

480,731

Today's Range

58.60

 - 

60.18

52 Week Range

43.36

 - 

67.66

As of on the XETRA ∙ Minimum 15 minute delay

Latest Developments

FDA Grants Emergency Use Authorization To Siemens Healthineers AG's Clinitest Rapid COVID-19 Antigen Self-Test

Dec 30 (Reuters) - Siemens Healthineers AG <SHLG.DE>::FDA, IN LETTER OF AUTHORIZATION, SAYS GRANTS EMERGENCY USE AUTHORIZATION TO SIEMENS HEALTHINEERS AG'S CLINITEST RAPID COVID-19 ANTIGEN SELF-TEST.Further company coverage: SHLG.DE. ((Reuters.Briefs@thomsonreuters.com;;)).

Siemens Healthineers Announces FDA Emergency Use Authorization For Its COVID-19 Test

Dec 29 (Reuters) - Siemens Healthineers AG <SHLG.DE>::SIEMENS HEALTHINEERS ANNOUNCES FDA EMERGENCY USE AUTHORIZATION FOR CLINITEST® RAPID COVID-19 ANTIGEN SELF-TEST.SIEMENS HEALTHINEERS AG - TEST IS EXPECTED TO BE AVAILABLE STARTING IN JANUARY.

Siemens Healthineers Accelerates Growth, Starts Third Phase Of Its 2025 Strategy

Nov 17 (Reuters) - SIEMENS HEALTHINEERS AG <SHLG.DE>::ACCELERATES GROWTH AND STARTS THIRD PHASE OF ITS 2025 STRATEGY.SECOND STRATEGY PHASE "UPGRADING" COMPLETED ONE YEAR AHEAD OF SCHEDULE.THIRD PHASE "NEW AMBITION" ADDRESSES BIGGEST OPPORTUNITIES IN HEALTHCARE: COMBATING SERIOUS DISEASES, SUPPORTING EFFICIENT WORKFLOWS, IMPROVING ACCESS TO HEALTHCARE.SEES COMPARABLE SALES GROWTH OF 6 TO 8 PERCENT P.A. AND ADJUSTED EPS GROWTH OF 12 TO 15 PERCENT P.A. IN FISCAL YEARS 2023 TO 2025.FOR VARIAN SEES TOTAL SYNERGIES OF MORE THAN 350 MILLION EUROS AND MARGIN OF WELL OVER 20 PERCENT PLANNED BY 2025.Further company coverage: SHLG.DE. (Gdansk Newsroom). ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;)).

Siemens Healthineers Sees 2022 Adj Basic EPS of 2.08-2.20 Euros

Nov 4 (Reuters) - Siemens Healthineers <SHLG.DE>::Q4 GROUP REVENUE 5.16 BILLION EUROS VERSUS COMPANY-PROVIDED ANALYST CONSENSUS FOR 5.05 BILLION EUROS.Q4 NET PROFIT 466 MILLION EUROS VERSUS CONSENSUS FOR 417 MILLION EUROS.SAYS SEES 2022 ADJUSTED BASIC EPS OF 2.08-2.20 EUROS.SAYS SEES FY 2022 COMPARABLE REVENUE GROWTH OF 0-2%.Q4 ADJUSTED EBIT 793 MILLION EUROS VERSUS CONSENSUS FOR 898 MILLION EUROS.SAYS EXCLUDING REVENUE FROM RAPID COVID-19 ANTIGEN TESTS, COMPARABLE REVENUE TO GROW BY BETWEEN 5% AND 7% IN 2022.

Teamviewer And Siemens Healthineers Form Partnership To Enable WeScan

Aug 5 (Reuters) - TEAMVIEWER AG <TMV.DE>::TEAMVIEWER AND SIEMENS HEALTHINEERS FORM PARTNERSHIP TO ENABLE NEW REMOTE SCANNING SERVICE WESCAN FOR DIAGNOSTIC IMAGING.

Siemens Healthineers Raises Guidance After Q3 Results

July 30 (Reuters) - Siemens Healthineers <SHLG.DE>::RAISES GUIDANCE, NOW SEES FY COMPARABLE REVENUE GROWTH OF 17-19% VERSUS PREVIOUSLY 14%-17%.SAYS NOW EXPECTS DIGNOSTICS SEGMENT WILL GENERATE AROUND €1 BILLION REVENUE FROM RAPID COVID-19 ANTIGEN TESTS (PREVIOUSLY AROUND €750 MILLION.SAYS NOW EXPECTS ADJUSTED BASIC EPS OF €1.95 - €2.05.SAYS CHANGED OUTLOOK PRIMARILY BASED ON HIGHER REVENUE EXPECTATIONS FOR IMAGING SEGMENT, RAPID COVID-19 ANTIGEN TESTS OF THE DIAGNOSTICS SEGMENT.SAYS ASSUME THAT PANDEMIC-RELATED DEMAND WILL NOT PERSIST TO THE SAME EXTENT IN THE FOURTH QUARTER AND BEYOND THE FISCAL YEAR 2021..SAYS REVENUE FROM RAPID COVID-19 ANTIGEN TESTS REACHES PEAK IN Q3, DIAGNOSTICS REVENUE POSTS COMPARABLE GROWTH OF 103.4%.Q3 GROUP REVENUE 5.00 BILLION EUROS VERSUS YEAR-EARLIER 3.31 BILLION.Q3 GROUP ADJUSTED EBIT 945 MILLION EUROS VERSUS YEAR-EARLIER 465 MILLION.Q3 GROUP BASIC EPS 0.35 EUROS VERSUS YEAR-EARLIER 0.27 EUROS.

Siemens Healthineers And Prisma Health Announce JV

June 22 (Reuters) - SIEMENS HEALTHINEERS AG <SHLG.DE>::SIEMENS HEALTHINEERS AND PRISMA HEALTH JOIN FORCES TO INNOVATE HEALTHCARE FOR SOUTH CAROLINA.ANNOUNCED TODAY A 10-YEAR STRATEGIC RELATIONSHIP TO HELP CREATE A BETTER STATE OF HEALTH FOR SOUTH CAROLINA.

Siemens Healthineers Says Determines Placement Price For New Shares From Capital Increase

March 24 (Reuters) - Siemens Healthineers AG <SHLG.DE>::DGAP-ADHOC: SIEMENS HEALTHINEERS AG: SIEMENS HEALTHINEERS DETERMINES THE PLACEMENT PRICE FOR THE NEW SHARES FROM THE CAPITAL INCREASE.SIEMENS HEALTHINEERS-TO INCREASE SHARE CAPITAL THROUGH PARTIAL UTILIZATION OF AUTHORIZED CAPITAL UNDER EXCLUSION OF SHAREHOLDERS' SUBSCRIPTION RIGHTS.SHARES WERE PLACED AT A PLACEMENT PRICE OF EUR 44.10 PER SHARE.INCREASE ITS SHARE CAPITAL FROM EUR 1,075,000,000 BY EUR 53,000,000 TO EUR 1,128,000,000.APPROXIMATELY 16.2% OF OFFER SIZE WAS ALLOCATED TO QATAR INVESTMENT AUTHORITY (QIA).

Siemens Healthineers AG Primary ABB Books Are Closed - Bookrunner

March 24 (Reuters) - Siemens Healthineers AG <SHLG.DE>::BLOCKTRADE-SIEMENS HEALTHINEERS AG PRIMARY ABB: BOOKRUNNER SAYS BOOKS ARE CLOSED, ALLOCATIONS WILL BE COMMUNCIATED TOMORROW MORNING BEFORE MARKET OPEN.

Siemens Healthineers Primary ABB Orders Below EUR44.10 Risk Missing - Bookrunner

March 24 (Reuters) - :BLOCKTRADE - SIEMENS HEALTHINEERS PRIMARY ABB: BOOKRUNNER SAYS ORDERS BELOW EUR44.10 RISK MISSING; BOOKS CLOSING AT 8:00PM UKT / 9:00PM CET.Further company coverage: SHLG.DE. ((Reuters.Briefs@thomsonreuters.com;)).

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up